GlassScriptPhysician profile
James T Elrod
NPI 1063467876
$614.94
in general payments reported to CMS, 2019-2025
7 companies · $66.77 in 2025
The $66.77 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.12 · 2021: $163 · 2022: $84.94 · 2023: $87.28 · 2024: $121 · 2025: $66.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $274.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $242.37 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $128.38 | 2019-2022 | |
| Glaxosmithkline, LLC. | $82.47 | 2023-2024 | Arexvy, Shingrix, Bexsero |
| Radius Health, INC. | $66.77 | 2025 | Tymlos |
| Pfizer INC. | $39.30 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $37.70 | 2022 | |
| Amarin Pharma, INC. | $17.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Elrod listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.